Amid all the volatility, some companies are proving resilient by performing much better than the market. Some of these look ...

Amgen's strategic growth through M&A and R&D investments has led to a diversified portfolio. Find out why I give AMGN stock a ...

In the latest trading session, Amgen (AMGN) closed at $277.29, marking a -1.89% move from the previous day. This change lagged the S&P 500's 0.13% gain on the day. At the same time, the Dow lost 1.33% ...

Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen ...

In the latest trading session, Amgen (AMGN) closed at $277.29, marking a -1.89% move from the previous day. This change lagged the S&P 500's 0.13% gain on the day. At the same time, the Dow lost 1 ...